Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) headquartered in Melbourne, Australia and Indianapolis, appoints two new Non-Executive Directors (NED) to its Board, effective May 11, 2026. This expansion and succession planning bring the total number of directors on the Board to (insert number).